Tranexamic Acid Treatment for Heavy Menstrual Bleeding
- 1 October 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 116 (4), 865-875
- https://doi.org/10.1097/aog.0b013e3181f20177
Abstract
To assess the efficacy and safety of an oral formulation of tranexamic acid for the treatment of heavy menstrual bleeding. Adult women with heavy menstrual bleeding (mean menstrual blood loss 80 mL or more per cycle) were enrolled in a double-blind, placebo-controlled study. After two pretreatment menstrual cycles, women were randomized to receive tranexamic acid 3.9 g/d or placebo for up to 5 days per menstrual cycle through six cycles. To meet the prespecified three-component primary efficacy end point, mean reduction in menstrual blood loss from baseline with tranexamic acid treatment needed to be 1) significantly greater than placebo, 2) greater than 50 mL, and 3) greater than a predetermined meaningful threshold (36 mL or higher). Health-related quality of life was measured using a validated patient-reported outcome instrument. Women who received tranexamic acid (n=115) met all three primary efficacy end points: first, a significantly greater reduction in menstrual blood loss of −69.6 mL (40.4%) compared with −12.6 mL (8.2%) in the 72 women who received placebo (P<.001); reduction of menstrual blood loss exceeding a prespecified 50 mL; and last, reduction of menstrual blood loss considered meaningful to women. Compared with women receiving placebo, women treated with tranexamic acid experienced significant improvements in limitations in social or leisure and physical activities, work inside and outside the home, and self-perceived menstrual blood loss (P<.01). The majority of adverse events were mild to moderate in severity, and the incidence of gastrointestinal adverse events was comparable with placebo. In this study, a new oral tranexamic acid treatment was well tolerated and significantly improved both menstrual blood loss and health-related quality of life in women with heavy menstrual bleeding. ClinicalTrials.gov, www.clinicaltrials.gov, NCT00386308. IKeywords
This publication has 23 references indexed in Scilit:
- Hemoglobin levels predict quality of life in women with heavy menstrual bleedingArchiv für Gynäkologie, 2009
- A Benefit-Risk Review of Systemic Haemostatic AgentsDrug Safety, 2008
- Diagnosis and treatment of menorrhagiaActa Obstetricia et Gynecologica Scandinavica, 2007
- A Systematic Review Evaluating Health-Related Quality of Life, Work Impairment, and Health-Care Costs and Utilization in Abnormal Uterine BleedingValue in Health, 2007
- Tranexamic AcidDrugs, 2003
- Determination of total menstrual blood lossFertility and Sterility, 2001
- Quality of Life and Patient Satisfaction Following Treatment for MenorrhagiaFamily Practice, 1994
- The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acidEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1987
- Menorrhagia.BMJ, 1987
- Menstrual Blood Loss–A Population StudyActa Obstetricia et Gynecologica Scandinavica, 1966